Clinical Trials Directory

Trials / Unknown

UnknownNCT03504449

Surgery Without Neoadjuvant Chemoradiotherapy Compared With Neoadjuvant Chemoradiotherapy for Rectal Cancer With Negative Circumferential Resection Margin Based on MRI Assessment, a Perspective Multicenter Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
350 (estimated)
Sponsor
Beijing Chao Yang Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

For now, neoadjuvant chemoradiotherapy is routinely performed for T3N1-2M0 rectal cancer. However, there are lots of complications following neoadjuvant chemoradiotherapy, such as Wound-related complications, anastomotic leakage, anastomotic stenosis, sexual dysfunction, testicular or ovary failure. Patients undergoing resection for rectal cancer had low rates of local recurrence and long disease-free survival regardless of whether an APR, CAA or low AR was performed. The main purpose of preoperative radiotherapy is to lower the local recurrence. For the T3N1-2M0 rectal cancer with negative circumferential resection margin based on MRI assessment, we suppose might not necessary to receive neoadjuvant chemoradiotherapy, for operation can achieve the negative circumferential resection margin.

Conditions

Interventions

TypeNameDescription
OTHERneoadjuvant chemoradiotherapy

Timeline

Start date
2016-12-01
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2018-04-20
Last updated
2021-02-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03504449. Inclusion in this directory is not an endorsement.